Literature DB >> 34182168

Post-intensive care syndrome in patients surviving COVID-19.

Camille Daste1, Simona Ficarra2, Alina Dumitrache3, Alain Cariou4, Aurélie Lefèbvre5, Frédéric Pène3, Nicolas Roche5, Alexandra Roren6, Camille Thery2, Jean Vidal3, Christelle Nguyen7, François Rannou8, Marie-Martine Lefèvre-Colau9.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34182168      PMCID: PMC8233854          DOI: 10.1016/j.rehab.2021.101549

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


× No keyword cloud information.
Dear Editor. We report the clinical manifestations of post-intensive care syndrome (PICS) in COVID-19 patients, resulting in aggregate physical, cognitive and mental impairments. Such impairments were previously described as new or worsening impairments in physical, cognitive, or mental health status arising after critical illness and persisting beyond acute care hospitalization [1]. They were formulated from an observational series of 45 of 51 consecutive patients with acute respiratory distress syndrome due to COVID-19 who were discharged from an intensive care unit (ICU) in France during the first epidemic wave. Between April and September 2020, all patients underwent similar evaluations in pneumology or physical medicine and rehabilitation (PMR) departments, within the first month and 3 months after ICU discharge in follow-up consultations, by physicians of two French PMR departments. All 51 patients were alive at 3 months after ICU discharge, but 6 could not be re-evaluated (refused an appointment at 3 months). In all 45 remaining patients, COVID-19 was confirmed by a positive RT-PCR test and/or consistent CT-scan results, assessed by trained radiologists (i.e., mainly ground-glass opacities with adequate pattern and distribution for COVID-19 diagnosis). Patient data are in the Table ; 37/45 (82%) patients were men, with mean (SD) age 58.0 (11.0) years (range 27–76). The mean length of ICU stay and invasive mechanical ventilation was 31.6 (16.1) and 25.4 (12.2) days, respectively; 34/45 (76%) patients underwent prone position sessions, with mean number of sessions 3.3 (2.7). All experienced at least one complication during the hospitalization in the ICU, mainly infection (37/45 [82%]), metabolic or ionic disorder (34/45 [76%]) or thromboembolic event (22/45 [49%]).
Table

Characteristics of patients with COVID-19 and intensive care unit (ICU) stay as well as post-ICU stay features at 1 and 3 months (n = 45).

Patient characteristics
Men37/45 (82)
Age (years), mean (SD)58.0 (11.0)
Body mass index (kg/m2), mean (SD)28.0 (4.6)
Professional categories

High professional occupation

6/45 (13.3)

Intermediate occupation and employees

11/45 (24.5)

Labourer, craftsman, farmer

14/45 (31.1)

Unemployed or retired

14/45 (31.1)
Medical history

High blood pressure

19/45 (42)

Diabetes

16/45 (36)

Obesity

13/45 (29)
ICU stay characteristics
Length of stay (days), mean (SD)31.6 (16.1)
Length of invasive mechanical ventilation (days), mean (SD)25.4 (12.2)
Tracheostomy7/45 (16)
Receiving extra-corporeal membrane oxygenation2/45 (5)
Duration (cumulated days) under neuroblockade agent, mean (SD)9.1 (5.9)
Weight loss in ICU (kg), mean (SD)−6.9 (13.4)a
Prone positioning34/45 (76)

number of sessions, mean (SD)

3.3 (2.7)b
Complications45/45 (100)

Infection

37/45 (82)

Metabolic or ionic disorder

34/45 (76)

Thromboembolic event

22/45 (49)

Neurological event

21/45 (47)

Other

35/45 (78)
Post-ICU syndromeAt 1 monthAt 3 months
Physical impairments

MRC score, mean (SD) /60

42.9 (11.2)c55.4 (6.7)

Critical illness neuromyopathy (MRC score <48/60)

26/44 (59)2/45 (4)

Central neurological manifestation

4/44 (9)3/45 (7)

Peripheral nerve injury

14/44 (32)27/45 (60)

Osteoarticular impairment

21/44 (48)37/45 (82)

Shoulder

17/44 (39)26/45 (58)

Other upper limb

4/44 (9)3/45 (7)

Lower limb

4/44 (9)9/45 (20)

Back pain

0/44 (0)5/45 (11)

Bedsores

20/45 (44)13/45 (29)

Dysphonia

NA17/45 (38)

Dysphagia

NA1/45 (2)

6MWT (m), mean (SD)

NA456.3 (158.1)c

Five-repetition sit-to-stand test (sec), mean (SD)

NA14.2 (5.0)d

Modified Borg Dyspnoea scale score, after 6MWT, mean (SD) /10

NA3.5 (2.2)c

SpO2 (%) at rest, mean (SD)

NA97.7 (1.3)

Post-exertion (6MWT) SpO2 (%), mean (SD)

NA97.3 (2.2)e
Cognitive impairment

Delirium

9/45 (20)NA

MoCA, mean (SD) /30

21.9 (6.0)f23.5 (5.5)e

Frontal Assessment Battery, mean (SD) /18

14.1 (3.8)g15.5 (2.4)c
Mental health impairments

HAD anxiety, mean (SD) /21

5.7 (3.5)b6.6 (5.1)d

Including patients with score ≥8/21

10/32 (31)16/42 (38)

HAD depression, mean (SD) /21

4.4 (3.5)b6.6 (5.4)d

Including patients with score ≥8/21

6/32 (29)15/45(36)

PCL-S, mean (SD) /85

NA36.4 (18.5)h

Including patients with score ≥ 34/85

NA15/35 (43)
Other

Hospitalization in PMR department

NA40/45 (89)

Length of stay in PMR (days), mean (SD)

NA27.5 (17.8)

Activities of daily living score /6, median (IQR)

4.5 (3–6)f6 (5.5–6)e

Return to home

NA44/45 (98)

Total length of hospital stay (days), mean (SD)

NA74.0 (26.8)c

Return to work

NA8/31 (26)

Data are n/N (%) unless otherwise indicated.

n = 33.

n = 32.

n = 44.

n = 42.

n = 43.

n = 38.

n = 37.

n = 35.

6MWT, Six-min walk test; HAD, Hospital Anxiety and Depression scale; MoCA, Montreal Cognitive Assessment questionnaire; MRC, Medical Research Council; PCL-S, Posttraumatic stress disorder CheckList-Simple; PMR, physical medicine and rehabilitation; NA, not assessed.

Characteristics of patients with COVID-19 and intensive care unit (ICU) stay as well as post-ICU stay features at 1 and 3 months (n = 45). High professional occupation Intermediate occupation and employees Labourer, craftsman, farmer Unemployed or retired High blood pressure Diabetes Obesity number of sessions, mean (SD) Infection Metabolic or ionic disorder Thromboembolic event Neurological event Other MRC score, mean (SD) /60 Critical illness neuromyopathy (MRC score <48/60) Central neurological manifestation Peripheral nerve injury Osteoarticular impairment Shoulder Other upper limb Lower limb Back pain Bedsores Dysphonia Dysphagia 6MWT (m), mean (SD) Five-repetition sit-to-stand test (sec), mean (SD) Modified Borg Dyspnoea scale score, after 6MWT, mean (SD) /10 SpO2 (%) at rest, mean (SD) Post-exertion (6MWT) SpO2 (%), mean (SD) Delirium MoCA, mean (SD) /30 Frontal Assessment Battery, mean (SD) /18 HAD anxiety, mean (SD) /21 Including patients with score ≥8/21 HAD depression, mean (SD) /21 Including patients with score ≥8/21 PCL-S, mean (SD) /85 Including patients with score ≥ 34/85 Hospitalization in PMR department Length of stay in PMR (days), mean (SD) Activities of daily living score /6, median (IQR) Return to home Total length of hospital stay (days), mean (SD) Return to work Data are n/N (%) unless otherwise indicated. n = 33. n = 32. n = 44. n = 42. n = 43. n = 38. n = 37. n = 35. 6MWT, Six-min walk test; HAD, Hospital Anxiety and Depression scale; MoCA, Montreal Cognitive Assessment questionnaire; MRC, Medical Research Council; PCL-S, Posttraumatic stress disorder CheckList-Simple; PMR, physical medicine and rehabilitation; NA, not assessed. During the first month after ICU discharge, the most frequent physical PICS manifestation was neurological impairment, with ICU-acquired weakness, defined as a Medical Research Council (MRC) score <48/60 [2], in 26/44 (59%) patients, and/or peripheral nerve injury in 14/44 (32%). Only 4/45 (9%) patients had central neurological manifestations: 2 with seizures, 1 encephalopathy and 1 cerebral haemorrhage. In all, 21/44 (48%) patients exhibited osteoarticular impairment, defined as pain and/or joint stiffness, especially in the upper limb, and 20/45 (44%) had bedsores, including 15 localizations consistent with prone positioning (i.e., face, chest and anterior tibial). Cognitive PICS manifestations were delirium, defined as time and space disorientation, hallucination, disturbed wake–sleep cycles and/or motor agitation (9/45 [20%] patients) and altered mean Montreal Cognitive Assessment questionnaire (MoCA) and/or Frontal Assessment Battery (FAB) scores: 21.9/30 (6.0) and 14.1/18 (3.8), respectively. Mental PICS manifestations were anxiety and depression, with mean scores on the Hospital Anxiety and Depression subscales of 5.7/21(3.5) and 4.4/21 (3.5). At 3 months after ICU discharge, the most frequent physical PICS manifestation was osteoarticular impairment, in particular of the shoulder (26/45 [58%] patients), including 4 retractile capsulitis cases confirmed by MRI and 22 rotator cuff decompensations. A total of 27/45 (60%) patients had peripheral nerve injury, mainly sensitive nerve injury occulted at 1 month because of tiredness or agitation, and only 2/45 (4%) had persistent ICU-acquired weakness. Functional capacity was assessed with the modified Borg Dyspnoea scale, after the 6-min walk test, with mean score 3.5/10 (2.2); the mean SpO2 (%) at rest and after exertion was 98% (1.3) and 97% (2.2); the mean 6-min walk test score was 456.3 (158.1) m and the mean score of 5 repetitions of the sit-to-stand test was 14.2 (5.0) sec, below the expected values for healthy adults of the same age: 588 m and 7.7 s [3], [4], [5], respectively. The mean MocA and FAB scores were 23.5/30 (5.5) and 15.5/18 (2.4). The mean anxiety and depression scores on the Hospital Anxiety and Depression subscales were 6.6/21 (5.1) and 6.6/21 (5.4), and the mean Post-traumatic stress disorder CheckList-Simple (PCL-S) score was 36.4/85 (18.5). Median (interquartile range) activities of daily living score was 6 (5.5–6). Overall, 40/45 (89%) patients were hospitalized in a PMR department, 44/45 (98%) had returned home after a mean hospital stay of 74.0 (26.8) days, and 8/31 (26%) had returned to work. In this consecutive series of COVID-19 patients surviving an ICU stay in the first COVID-19 wave in France, all experienced at least one physical impairment during the first month after ICU discharge. At 3 months, most patients still had clinically relevant physical impairment, with a high prevalence of shoulder and peripheral nerve injuries. Overall, 20% of patients exhibited delirium, a clinical expression of acute brain dysfunction, and all experienced cognitive disorder, such as memory loss or difficulty in executive functions, during the first month after ICU discharge. At 3 months, memory, attention, processing speed and executive function remained altered, and most patients did not fully recover in these areas (MocA score <26/30 and FAB score <16/18) [6,7]. For one third of patients, the anxiety and depression scores were clinically significant (>7/21) [8] at 1 and 3 months, and for more than 40% of the patients, the PCL-S score (>34) at 3 months was consistent with a possible post-traumatic stress disorder [9] possibly requiring psychological follow-up. This finding agrees with a recent study regarding the risk of psychiatric sequelae after a COVID-19 episode [10]. COVID-19 patients surviving an ICU stay can exhibit several well-identified risk factors of PICS, including prolonged mechanical ventilation (>7 days), use of a neuromuscular blocking agent and acute respiratory distress syndrome [11]. Long-term evolution is unknown, and data are lacking to determine whether neurological complications are related to direct or indirect viral action [12]. However, in this series, physical, psychological and cognitive impairments were similar to those usually observed in non-COVID patients surviving an ICU stay [13], [14], [15], [16], [17], [18], and all patients but one had returned home and recovered sufficient autonomy despite remaining with osteoarticular and neuro-psychological impairment. These findings highlight the importance of early and multidisciplinary rehabilitation in managing PICS in survivors of an ICU stay during and after the pandemic [19,20].
  19 in total

1.  Six minute walk distance in healthy subjects aged 55-75 years.

Authors:  Bernadine Camarri; Peter R Eastwood; Nola M Cecins; Philip J Thompson; Sue Jenkins
Journal:  Respir Med       Date:  2005-10-17       Impact factor: 3.415

Review 2.  Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference.

Authors:  Dale M Needham; Judy Davidson; Henry Cohen; Ramona O Hopkins; Craig Weinert; Hannah Wunsch; Christine Zawistowski; Anita Bemis-Dougherty; Susan C Berney; O Joseph Bienvenu; Susan L Brady; Martin B Brodsky; Linda Denehy; Doug Elliott; Carl Flatley; Andrea L Harabin; Christina Jones; Deborah Louis; Wendy Meltzer; Sean R Muldoon; Jeffrey B Palmer; Christiane Perme; Marla Robinson; David M Schmidt; Elizabeth Scruth; Gayle R Spill; C Porter Storey; Marta Render; John Votto; Maurene A Harvey
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

3.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 4.  Long-term complications of critical care.

Authors:  Sanjay V Desai; Tyler J Law; Dale M Needham
Journal:  Crit Care Med       Date:  2011-02       Impact factor: 7.598

5.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

6.  Physical Impairments Associated With Post-Intensive Care Syndrome: Systematic Review Based on the World Health Organization's International Classification of Functioning, Disability and Health Framework.

Authors:  Patricia J Ohtake; Alan C Lee; Jacqueline Coffey Scott; Rana S Hinman; Naeem A Ali; Carl R Hinkson; Dale M Needham; Lori Shutter; Helene Smith-Gabai; Mary C Spires; Alecia Thiele; Clareen Wiencek; James M Smith
Journal:  Phys Ther       Date:  2018-08-01

7.  Shoulder Impairment Following Critical Illness: A Prospective Cohort Study.

Authors:  Owen D Gustafson; Matthew J Rowland; Peter J Watkinson; Stuart McKechnie; Simon Igo
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

Review 8.  COVID-19: ICU delirium management during SARS-CoV-2 pandemic.

Authors:  Katarzyna Kotfis; Shawniqua Williams Roberson; Jo Ellen Wilson; Wojciech Dabrowski; Brenda T Pun; E Wesley Ely
Journal:  Crit Care       Date:  2020-04-28       Impact factor: 9.097

9.  Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.

Authors:  Maxime Taquet; Sierra Luciano; John R Geddes; Paul J Harrison
Journal:  Lancet Psychiatry       Date:  2020-11-09       Impact factor: 27.083

10.  COVID-19 recovery: potential treatments for post-intensive care syndrome.

Authors:  Mansoor N Bangash; Andrew Owen; Joseph E Alderman; Minesh Chotalia; Jaimin M Patel; Dhruv Parekh
Journal:  Lancet Respir Med       Date:  2020-10-12       Impact factor: 30.700

View more
  2 in total

1.  Moderate, Little, or No Improvements in Neurobehavioral Symptoms among Individuals with Long COVID: A 34-Country Retrospective Study.

Authors:  Daniela Ramos-Usuga; Paul B Perrin; Yelena Bogdanova; Laiene Olabarrieta-Landa; Elisabet Alzueta; Fiona C Baker; Stella Iacovides; Mar Cortes; Juan Carlos Arango-Lasprilla
Journal:  Int J Environ Res Public Health       Date:  2022-10-02       Impact factor: 4.614

Review 2.  Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review.

Authors:  Charikleia S Vrettou; Vassiliki Mantziou; Alice G Vassiliou; Stylianos E Orfanos; Anastasia Kotanidou; Ioanna Dimopoulou
Journal:  Life (Basel)       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.